Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.57%
#2 Movement Movement +6.40%
#3 Palladium Network Palladium Network +5.02%
#4 Prom Prom +4.17%
#5 GRVT Token GRVT Token +3.87%
#6 Cryptopia Cryptopia +3.74%
#7 SIXSEVEN SIXSEVEN +3.67%
#8 Test Test +3.60%
#9 Kinetiq Kinetiq +3.58%
#10 Jito Jito +3.53%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Entia Biosciences, Inc. Entia Biosciences, Inc.

Entia Biosciences, Inc.

ERGO
Classifica tra le azioni #41967
Entia Biosciences, Inc. engages in the development, production, and... Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products. In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon.
Prezzo delle azioni
$0.0002
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$6.73K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
100.00%
Paese
US
Scambia Entia Biosciences, Inc. (ERGO)

Categoria

Healthcare
Storico del rendimento da dividendi per Entia Biosciences, Inc. (ERGO)
Il rendimento da dividendi (TTM) di Entia Biosciences, Inc. (simbolo azionario: ERGO) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Entia Biosciences, Inc. (ERGO) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
1.56%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
0.00%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
0.00%
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
0.00%
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
0.00%
US